Degree of ST-segment elevation in patients with STEMI reflects the acute ischemic burden and the salvage potential

Divan Gabriel Topal1, Thomas Engstrøm2, Lars Nepper-Christensen1

  • 1Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark.

Insights

The sum of ST-segment elevation (∑STE) on ECG before primary percutaneous coronary intervention (PPCI) correlates with myocardial damage in ST-segment elevation myocardial infarction (STEMI) patients. This ECG marker helps predict infarct size and salvage, guiding treatment decisions.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Biomedical Engineering

Background:

  • ST-segment elevation myocardial infarction (STEMI) diagnosis relies on electrocardiogram (ECG) ST-segment elevation (STE).
  • The prognostic significance of the sum of STE (∑STE) before primary PCI (PPCI) is not fully understood.
  • This study investigates the association between ∑STE and infarct characteristics.

Purpose of the Study:

  • To evaluate the relationship between pre-PPCI ∑STE and the area at risk, infarct size, and myocardial salvage in STEMI patients.
  • To determine if pre-PPCI ∑STE can predict myocardial damage extent.
  • To explore the influence of coronary blood flow (TIMI flow) on this association.

Main Methods:

  • Cardiac magnetic resonance (CMR) was used to assess infarct size and area at risk in 503 STEMI patients.
  • CMR imaging was performed at day 1 and day 92 post-STEMI.
  • The sum of ST-segment elevation (∑STE) from the ECG prior to PPCI was analyzed in relation to CMR findings and pre-PPCI TIMI flow.

Main Results:

  • ∑STE demonstrated a linear association with increased area at risk, larger final infarct size, and greater microvascular obstruction.
  • ∑STE was inversely associated with final myocardial salvage.
  • This association between ∑STE and myocardial salvage was significant in patients with pre-PPCI TIMI flow 2/3, but not in those with TIMI flow 0/1.

Conclusions:

  • Pre-PPCI ∑STE is a valuable ECG marker for assessing the extent of myocardium at risk in STEMI.
  • In patients with TIMI flow 0/1, ∑STE reflects the area at risk influencing infarct size.
  • In patients with TIMI flow 2/3, ∑STE indicates both the area at risk and myocardial salvage, impacting overall myocardial damage.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
451
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
117
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
236
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
128
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
631